ORBIMED ADVISORS LLC

Holdings History for Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Symbol: PRLD on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.68%	0%	$31,636,842	10,909,256	0		$2.90	Q4 2025
30 Sep 2025	0.38%	0%	$15,709,329	10,909,256	0		$1.44	Q3 2025
30 Jun 2025	0.22%	0%	$8,829,952	10,909,256	0		$0.81	Q2 2025
31 Mar 2025	0.2%	0%	$8,378,309	10,909,256	0		$0.77	Q1 2025
31 Dec 2024	0.29%	0%	$13,909,301	10,909,256	0		$1.27	Q4 2024
30 Sep 2024	0.41%	0%	$22,582,160	10,909,256	0		$2.07	Q3 2024
30 Jun 2024	0.89%	0%	$41,564,265	10,909,256	0		$3.81	Q2 2024
31 Mar 2024	1%	0%	$51,709,873	10,909,256	0		$4.74	Q1 2024
31 Dec 2023	0.93%	0%	$46,582,523	10,909,256	0		$4.27	Q4 2023
30 Sep 2023	0.78%	0%	$33,709,601	10,909,256	0		$3.09	Q3 2023
30 Jun 2023	0.96%	+0.08%	$49,091,652	10,909,256	+869,565	+8.7%	$4.50	Q2 2023
31 Mar 2023	1.1%	0%	$57,226,239	10,039,691	0		$5.70	Q1 2023
31 Dec 2022	1.2%	0%	$60,639,734	10,039,691	0		$6.04	Q4 2022
30 Sep 2022	1.4%	0%	$66,362,000	10,039,691	0		$6.61	Q3 2022
30 Jun 2022	1%	0%	$52,407,000	10,039,691	0		$5.22	Q2 2022
31 Mar 2022	1.1%	0%	$69,274,000	10,039,691	0		$6.90	Q1 2022
31 Dec 2021	1.7%	0%	$124,994,000	10,039,691	0		$12.45	Q4 2021
30 Sep 2021	3.6%	0%	$313,740,000	10,039,691	0		$31.25	Q3 2021
30 Jun 2021	3%	0%	$287,436,000	10,039,691	0		$28.63	Q2 2021
31 Mar 2021	4.3%	-2.4%	$435,020,000	10,039,691	-5,555,186	-36%	$43.33	Q1 2021
31 Dec 2020	9.8%	0%	$1,115,813,000	15,594,877	0		$71.55	Q4 2020
30 Sep 2020	6%	+6%	$469,874,000	15,594,877	+15,594,877	NEW	$30.13	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.